Skip to main content
Clinical Trials/EUCTR2018-002376-41-DK
EUCTR2018-002376-41-DKActive, not recruitingPhase 1

Modulating the Vaginal Microbiome after Implantation Failure -A randomized placebo controlled study of lactobacilli supplements

Zealand University Hospital, Gynecological department0 sites74 target enrollmentStarted: August 17, 2018Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
74

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • Sub-optimal microbiome diagnosed
  • Age < 43 years
  • non-smoker
  • Included in RIF-project and agreed to be contacted in case of other research study
  • Diagnosed with a sub-optimal microbiome following testing in our fertility clinic
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 74
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Age < 18 years
  • Use of antibiotics and/or porbiotics between diagnose and inclusion
  • Pregnant at enrollment
  • Allergy towards the study drug

Investigators

Sponsor
Zealand University Hospital, Gynecological department

Similar Trials